Public Charity

BIOMEDICAL EXCELLENCE FOR SAFER TRANSFUSION COLLABORATIVE

BIOMEDICAL EXCELLENCE FOR SAFER TRANSFUSION COLLABORATIVE is a nonprofit organization categorized as Public Charity based in LEBANON, NH. Its most recent IRS filing (2025) reports revenue of $362K, expenses of $377K, total assets of $737K.

EIN: 050602179 LEBANON, NH Latest filing: 2025

Total Revenue$362K

Total Expenses$377K

Total Assets$737K

Grant Records0

Filing Years2021–2025

Mission

WE'RE A UNIQUE INTERNATIONAL COLLABORATIVE OF BLOOD PROVIDERS, INDUSTRY AND ACADEMIC EXPERTS. THROUGH WORKING TOGETHER TO UNDERTAKE STUDIES, PUBLISHING GUIDANCE AND RECOMMENDING PROCEDURES, WE AIM TO IMPROVE THE SAFETY, QUALITY, AND EFFECTIVENESS OF TRANSFUSION MEDICINE AND CELLULAR THERAPIES WORLDWIDE. WE USE OUR POOLED RESOURCES TO TAKE ON PROJECTS AND CHALLENGES THAT WOULD BE UNFEASIBLE TO ADDRESS OTHERWISE. WE CREATE INTERNATIONAL IMPACT IN TRANSFUSION AND CELLULAR THERAPIES FOR THE BENEFIT OF DONORS AND PATIENTS.

Where $100 goes at Biomedical Excellence for Safer Transfusion Collaborative

How Biomedical Excellence for Safer Transfusion Collaborative divides every $100 it spends, from its own Form 990 filings, averaged across 6 years.

$79 Programs the work itself

$21 Management running the organization

$0 Fundraising none reported

No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.

Inside the $79 for programs

$79

Delbaugh rm, murphy mf, staves j, fachini rm, wendel s, hands k, bonet-bub c, kutner jm, cohn cs, cox ca, jacquot c, hasan ra, lu w, juskewitch je…

All program spending

Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.

Officers & Directors

DIRECTOR David Mckenna

DIRECTOR David Stroncek

DIRECTOR Denese Marks

EXECUTIVE DIRECTOR Eileen Selogie

EXECUTIVE DIRECTOR Ernest Ho

DIRECTOR Jason Acker

Officer compensation and complete director data available with membership.

Financial Trends

Year	Revenue	Expenses	Assets
2025	$362K	$377K	$737K
2024	$355K	$449K	$751K
2023	$330K	$395K	$837K
2022	$379K	$300K	$902K
2021	$368K	$162K	$823K

Between 2021 and 2025, reported annual revenue held roughly steady at around $362K, with total assets most recently reported at $737K.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for BIOMEDICAL EXCELLENCE FOR SAFER TRANSFUSION COLLABORATIVE

Complete financials, all 0 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 880,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports